Gammaplex 20 GM per 400 ML Injection
- RxCUI
- 1809514
- RxNorm name
- Gammaplex 20 GM per 400 ML Injection
- Display name
- Gammaplex 20 GM per 400 ML Injection
- Full name
- Gammaplex 20 GM per 400 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125329 | Gammaplex | Immune Globulin Intravenous (Human) | 351(a) | Disc | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6c3ce068-59f0-413b-9f93-85fb597d55e5 | Gammaplex 5 % in 400 ML Injection [PSN] · 400 ML immunoglobulin G, human 50 MG/ML Injection [Gammaplex] [SBD] · 400 ML Gammaplex 50 MG/ML Injection [SY] · Gammaplex 20 GM per 400 ML Injection [SY] · Gammaplex 5 % per 400 ML Injection [SY] | 5 | 26 | These highlights do not include all the information needed to use GAMMAPLEX 5% ® safely and effectively. See full prescribing information for GAMMAPLEX 5% ® . GAMMAPLEX 5% Immune Globulin Intravenous (Human), 5% Liquid, for intravenous use Initial U.S. Approval: 2009 | 20250916 |